MAPT and Alzheimer disease: One possible explanation for this lack of diagnostic sensitivity is that impaired blood-brain barrier (BBB) not only occurs in AD patients but also in normal elderly individuals with early cognitive dysfunctions [36], thereby affecting plasma t-tau concentration in an unpredictable manner.